/IMRSQ

IMRSQ Stock - IMRIS Inc.

Q: What is the analyst price target for IMRSQ?

Analyst price target information is not currently available for IMRSQ.

Q: What is IMRSQ's market cap?

Market capitalization information is not currently available for IMRSQ.

Healthcare|Medical - Specialties|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for IMRSQ

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2010

FY2011

FY2012

FY2013

FY2014

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta7.79

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2014	FY2013	FY2012	FY2011	FY2010
Revenue	$28.89M	$46.04M	$52.39M	$51.80M	$70.28M
Gross Profit	$9.93M	$15.67M	$17.80M	$17.67M	$30.67M
Gross Margin	34.4%	34.0%	34.0%	34.1%	43.6%
Operating Income	$-23,140,000	$-39,305,000	$-27,524,000	$-20,566,000	$-981,000
Net Income	$-30,387,000	$-42,000,000	$-27,756,000	$-20,925,000	$-1,766,000
Net Margin	-105.2%	-91.2%	-53.0%	-40.4%	-2.5%
EPS	$-0.58	$-0.83	$-0.61	$-0.47	$-0.04

Company Overview

IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Winnipeg, Canada.

Visit Website

Earnings History & Surprises

IMRSQ

Beat Rate

23%

Last 13 quarters

Avg Surprise

-55.2%

EPS vs Estimate

Beats / Misses

3/8

2 met exactly

Latest EPS

$-0.13

Q1 2015

EPS Surprise History

Q4 12

-35.7%

$-0.19vs$-0.14

Q2 13

-12.5%

$-0.18vs$-0.16

Q3 13

0.0%

$-0.16vs$-0.16

Q4 13

+36.4%

$-0.07vs$-0.11

Q2 14

-50.0%

$-0.15vs$-0.10

Q3 14

0.0%

$-0.14vs$-0.14

Q4 14

-33.3%

$-0.16vs$-0.12

Q1 15

-85.7%

$-0.13vs$-0.07

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2015	Mar 4, 2015	$-0.07	$-0.13	-85.7%	✗ MISS
Q4 2014	Oct 28, 2014	$-0.12	$-0.16	-33.3%	✗ MISS
Q3 2014	Aug 7, 2014	$-0.14	$-0.14	0.0%	= MET
Q2 2014	May 13, 2014	$-0.10	$-0.15	-50.0%	✗ MISS
Q4 2013	Nov 4, 2013	$-0.11	$-0.07	+36.4%	✓ BEAT
Q3 2013	Aug 13, 2013	$-0.16	$-0.16	0.0%	= MET
Q2 2013	May 2, 2013	$-0.16	$-0.18	-12.5%	✗ MISS
Q4 2012	Nov 8, 2012	$-0.14	$-0.19	-35.7%	✗ MISS
Q3 2012	Aug 9, 2012	$-0.14	$-0.09	+35.7%	✓ BEAT
Q2 2012	May 14, 2012	$-0.19	$-0.18	+5.3%	✓ BEAT
Q4 2011	Nov 14, 2011	$-0.05	$-0.19	-280.0%	✗ MISS
Q3 2011	Aug 9, 2011	$-0.04	$-0.06	-51.1%	✗ MISS
Q2 2011	May 12, 2011	$-0.03	$-0.10	-246.7%	✗ MISS